Recent FDA changes are limiting the legal availability of compounded glp-1s. Here’s what to know and how they differ from brand-name drugs.
This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight-loss medications for adults with obesity or with overweight and one weight-related health condition, have become extremely popular, in part due to off-label use. At SELF, our job is to keep you—our reader—informed, which is why we wrote the article below. While people can be healthy at every size, research suggests carrying extra weight may increase your risk for certain conditions.
The smaller 503A pharmacies, however, are exempt from CGMP and just need to be licensed by their state board of pharmacy, which requires following rules set by the United States Pharmacopeia instead. For sterile items like GLP-1s, this still involves things like monitoring the air and surfaces in the pharmacy for microbes, wearing sterile gloves, and the like, Dr. Ganio says.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Safety Concerns and Regulatory Challenges of Compounded GLP-1 MedicationsThis news discusses the safety concerns and regulatory challenges associated with compounded GLP-1 medications, particularly in the context of telemedicine services. It emphasizes the need for patient education and awareness regarding compounded medications and highlights the importance of discussing potential risks and benefits with healthcare providers.
Read more »
The End of Compounded GLP-1s: What Physicians Need to KnowFDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; physicians to stay cautious and inform patients about risks and alternatives.
Read more »
The GLP-1 Revolution — Everyone And Their Moms Are On GLP-1sThe business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact
Read more »
GLP-1 Drugs Are Sweeping the Medical ProfessionDoctors are noticing a trend among their colleagues: they seem to be getting full before finishing dinner, likely thanks to GLP-1 drugs like Ozempic. Medical professionals who use these popular weight loss drugs, which replicate the stomach's feeling of fullness, have begun noticing each other. While there aren't any surveys tracking how many physicians take these drugs or what doses they're on, several doctors have openly shared their experiences.
Read more »
Hims & Hers Weight Loss Ad Sparks Controversy Over Compounded Drugs and Advertising PracticesA recent Hims & Hers advertisement promoting compounded weight loss drugs has sparked debate regarding the safety and transparency of compounded medications and advertising practices.
Read more »
GLP-1 Weight Loss Drugs Changing Eating Habits and Restaurant IndustryThe rise of GLP-1 weight loss drugs like Ozempic and Wegovy is leading to a decrease in dining out and alcohol consumption. Studies show that people taking these drugs experience significant weight loss and altered food choices, impacting the restaurant industry.
Read more »